{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:22:41Z","timestamp":1791238961690,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T00:00:00Z","timestamp":1331164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11940-012-0171-z","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T09:59:11Z","timestamp":1331114351000},"page":"276-292","source":"Crossref","is-referenced-by-count":6,"title":["Neurologic Manifestations of Systemic Immunopathological Diseases"],"prefix":"10.1007","volume":"14","author":[{"given":"Marc","family":"Gotkine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Vaknin-Dembinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,8]]},"reference":[{"issue":"9","key":"171_CR1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"171_CR2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.1780350502","volume":"35","author":"MC Hochberg","year":"1992","unstructured":"Hochberg MC, et al. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35(5):498\u2013502.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"171_CR3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA. Systemic Lupus Erythematosus. New England Journal of Medicine. 2008;358(9):929\u201339.","journal-title":"New England Journal of Medicine"},{"key":"171_CR4","doi-asserted-by":"crossref","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42(10211873): 599\u2013608.","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"issue":"17698785","key":"171_CR5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","volume":"69","author":"FG Joseph","year":"2007","unstructured":"Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology. 2007;69(17698785):644\u201354.","journal-title":"Neurology"},{"issue":"15668428","key":"171_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000149640.78684.EA","volume":"64","author":"EY McLaurin","year":"2005","unstructured":"McLaurin EY, et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology. 2005;64(15668428):297\u2013303.","journal-title":"Neurology"},{"key":"171_CR7","doi-asserted-by":"crossref","unstructured":"Gotkine, M., Y. Fellig, O. Abramsky, Occurrence of CNS demyelinating disease in patients with myasthenia gravis (subsequent correspondence in Neurology 2007;68(16):1326\u20137). Neurology, 2006. 67(16966558): p. 881-883.","DOI":"10.1212\/01.wnl.0000234142.41728.a0"},{"issue":"15047589","key":"171_CR8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/brain\/awh146","volume":"127","author":"DD Mitsikostas","year":"2004","unstructured":"Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004;127(15047589):1200\u20139.","journal-title":"Brain"},{"issue":"16420554","key":"171_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(16420554):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"171_CR10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"WA Wilson","year":"1999","unstructured":"Wilson WA, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309\u201311.","journal-title":"Arthritis Rheum"},{"issue":"11567728","key":"171_CR11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(11567728):903\u201311.","journal-title":"Lancet"},{"issue":"16078320","key":"171_CR12","first-page":"1459","volume":"32","author":"JG Hanly","year":"2005","unstructured":"Hanly JG, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2005;32(16078320):1459\u20136.","journal-title":"J Rheumatol"},{"issue":"18084807","key":"171_CR13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-007-0804-x","volume":"27","author":"V Agarwal","year":"2008","unstructured":"Agarwal V, et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol. 2008;27(18084807):841\u20134.","journal-title":"Clin Rheumatol"},{"issue":"18575424","key":"171_CR14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.20452\/pamw.370","volume":"118","author":"J Kur-Zalewska","year":"2008","unstructured":"Kur-Zalewska J, Swarowska-Knap J, Tlustochowicz W. Neurological disorders with demyelinating brain white matter lesions in a patient with rheumatoid arthritis treated with etanercept. Pol Arch Med Wewn. 2008;118(18575424):234\u20137.","journal-title":"Pol Arch Med Wewn"},{"issue":"20185466","key":"171_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2008.160457","volume":"81","author":"N Bruggemann","year":"2010","unstructured":"Bruggemann N, et al. Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology. J Neurol Neurosurg Psychiatry. 2010;81(20185466):294\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"171_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83(5):280\u201391.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"171_CR17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094\u2013100.","journal-title":"Arthritis Rheum"},{"issue":"Pt 3","key":"171_CR18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/122.3.427","volume":"122","author":"N Hattori","year":"1999","unstructured":"Hattori N, et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain. 1999;122(Pt 3):427\u201339.","journal-title":"Brain"},{"issue":"4","key":"171_CR19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1468-1331.2009.02902.x","volume":"17","author":"J Wolf","year":"2010","unstructured":"Wolf J, et al. Neurologic complications of Churg-Strauss syndrome\u2013a prospective monocentric study. Eur J Neurol. 2010;17(4):582\u20138.","journal-title":"Eur J Neurol"},{"issue":"3","key":"171_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/qjmed\/91.3.219","volume":"91","author":"AJ Reid","year":"1998","unstructured":"Reid AJ, et al. Churg-Strauss syndrome in a district hospital. QJM. 1998;91(3):219\u201329.","journal-title":"QJM"},{"issue":"1","key":"171_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","volume":"78","author":"L Guillevin","year":"1999","unstructured":"Guillevin L, et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26\u201337.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"171_CR22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/rheumatology\/40.7.763","volume":"40","author":"R Solans","year":"2001","unstructured":"Solans R, et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology (Oxford). 2001;40(7):763\u201371.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"171_CR23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/rheumatology\/41.11.1286","volume":"41","author":"A Della Rossa","year":"2002","unstructured":"Della Rossa A, et al. Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology (Oxford). 2002;41(11):1286\u201394.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"171_CR24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4065\/70.4.337","volume":"70","author":"M Sehgal","year":"1995","unstructured":"Sehgal M, et al. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc. 1995;70(4):337\u201341.","journal-title":"Mayo Clin Proc"},{"issue":"1\u20132","key":"171_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2010.10.016","volume":"301","author":"NE Mencacci","year":"2011","unstructured":"Mencacci NE, et al. Intracerebral haemorrhage, a possible presentation in Churg-Strauss syndrome: case report and review of the literature. J Neurol Sci. 2011;301(1\u20132):107\u201311.","journal-title":"J Neurol Sci"},{"issue":"21","key":"171_CR26","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","volume":"337","author":"JC Jennette","year":"1997","unstructured":"Jennette JC, Falk RJ. Small-Vessel Vasculitis. New England Journal of Medicine. 1997;337(21):1512\u201323.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"171_CR27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.410330103","volume":"33","author":"H Nishino","year":"1993","unstructured":"Nishino H, et al. Neurological involvement in Wegener\u2019s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993;33(1):4\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"171_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0733-8619(03)00056-2","volume":"20","author":"SE Nadeau","year":"2002","unstructured":"Nadeau SE. Neurologic manifestations of systemic vasculitis. Neurol Clin. 2002;20(1):123\u201350.","journal-title":"Neurol Clin"},{"issue":"1","key":"171_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.nrl.0000252942.14928.17","volume":"13","author":"KC Gorson","year":"2007","unstructured":"Gorson KC. Vasculitic neuropathies: an update. Neurologist. 2007;13(1):12\u20139.","journal-title":"Neurologist"},{"issue":"1","key":"171_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1756285609347123","volume":"3","author":"P Berlit","year":"2010","unstructured":"Berlit P. Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord. 2010;3(1):29\u201342.","journal-title":"Ther Adv Neurol Disord"},{"issue":"16432246","key":"171_CR31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(16432246):577\u2013617.","journal-title":"Stroke"},{"issue":"3","key":"171_CR32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"171_CR33","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K Groot De","year":"2005","unstructured":"De Groot K, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52(8):2461\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"171_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","volume":"173","author":"KA Keogh","year":"2006","unstructured":"Keogh KA, et al. Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med. 2006;173(2):180\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"171_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221\u201332.","journal-title":"N Engl J Med"},{"issue":"6 Suppl 43","key":"171_CR36","first-page":"S-93","volume":"24","author":"C Mukhtyar","year":"2006","unstructured":"Mukhtyar C, et al. Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Clin Exp Rheumatol. 2006;24(6 Suppl 43):S-93\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"171_CR37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","volume":"79","author":"B Wilde","year":"2011","unstructured":"Wilde B, et al. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 2011;79(6):599\u2013612.","journal-title":"Kidney Int"},{"issue":"7","key":"171_CR38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archneurol.2011.34","volume":"68","author":"SM Magana","year":"2011","unstructured":"Magana SM, et al. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol. 2011;68(7):870\u20138.","journal-title":"Arch Neurol"},{"issue":"1","key":"171_CR39","first-page":"100","volume":"35","author":"M Faurschou","year":"2008","unstructured":"Faurschou M, et al. Malignancies in Wegener\u2019s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol. 2008;35(1):100\u20135.","journal-title":"J Rheumatol"},{"issue":"9","key":"171_CR40","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-129-9-199811010-00007","volume":"129","author":"AJ Black","year":"1998","unstructured":"Black AJ, et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med. 1998;129(9):716\u20138.","journal-title":"Ann Intern Med"},{"issue":"17428359","key":"171_CR41","first-page":"23","volume":"25","author":"B Brihaye","year":"2007","unstructured":"Brihaye B, et al. Adjunction of rituximab to steroids and immunosuppressants for refractory\/relapsing Wegener\u2019s granulomatosis: a study on 8 patients. Clin Exp Rheumatol. 2007;25(17428359):23\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"16950808","key":"171_CR42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","volume":"66","author":"R Seror","year":"2007","unstructured":"Seror R, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2007;66(16950808):351\u20137.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-012-0171-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-012-0171-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-012-0171-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T15:40:26Z","timestamp":1742658026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-012-0171-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,8]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1007\/s11940-012-0171-z","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,8]]}}}